Folgen
Fernando Fumagalli
Fernando Fumagalli
Professor Adjunto - UFSM
Bestätigte E-Mail-Adresse bei ufsm.br
Titel
Zitiert von
Zitiert von
Jahr
Arene‐Ligand‐Free Ruthenium(II/III) Manifold for meta‐C−H Alkylation: Remote Purine Diversification
F Fumagalli, S Warratz, SK Zhang, T Rogge, C Zhu, AC Stückl, ...
Chemistry–A European Journal 24 (16), 3984-3988, 2018
662018
In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy
MT Luiz, JP Abriata, GL Raspantini, LB Tofani, F Fumagalli, SMG de Melo, ...
Materials Science and Engineering: C 105, 110038, 2019
472019
In vivo antimalarial activity of novel 2-hydroxy-3-anilino-1, 4-naphthoquinones obtained by epoxide ring-opening reaction
LCD de Rezende, F Fumagalli, MS Bortolin, MG de Oliveira, MH de Paula, ...
Bioorganic & medicinal chemistry letters 23 (16), 4583-4586, 2013
472013
Cytotoxicity, hemolysis and in vivo acute toxicity of 2-hydroxy-3-anilino-1, 4-naphthoquinone derivatives
VS de Sena Pereira, CBS de Oliveira, F Fumagalli, F da Silva Emery, ...
Toxicology Reports 3, 756-762, 2016
452016
Charting the Chemical Reactivity Space of 2,3-Substituted Furo[2,3-b]pyridines Synthesized via the Heterocyclization of Pyridine-N-oxide Derivatives
F Fumagalli, F da Silva Emery
The Journal of Organic Chemistry 81 (21), 10339-10347, 2016
242016
Synthesis and Structure− Activity Relationships of Imidazopyridine/Pyrimidine‐and Furopyridine‐Based Anti‐infective Agents against Trypanosomiases
DG Silva, A Junker, SMG de Melo, F Fumagalli, JR Gillespie, N Molasky, ...
ChemMedChem 16 (6), 966-975, 2021
172021
Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase
FA Calil, JS David, ERC Chiappetta, F Fumagalli, RB Mello, FHA Leite, ...
European journal of medicinal chemistry 167, 357-366, 2019
172019
Palladium-catalyzed C–H alkenylation of quinoxaline N-oxide enabled by a mono-N-protected amino acid
MSF Franco, MH de Paula, PC Glowacka, F Fumagalli, GC Clososki, ...
Tetrahedron letters 59 (26), 2562-2566, 2018
162018
Novel benzophenone-3 derivatives with promising potential as UV filters: Relationship between structure, photoprotective potential and phototoxicity
MTP González, F Fumagalli, CG Benevenuto, F da Silva Emery, ...
European Journal of Pharmaceutical Sciences 101, 200-210, 2017
162017
Exploiting the furo [2, 3-b] pyridine core against multidrug-resistant Mycobacterium tuberculosis
F Fumagalli, SMG de Melo, CM Ribeiro, MC Solcia, FR Pavan, ...
Bioorganic & Medicinal Chemistry Letters 29 (8), 974-977, 2019
142019
Pd (II)-mediated cyclodehydrogenation of formyldiarylamines—total synthesis of natural carbazoles clauraila A, clausenal and 6-methoxymurrayanine
F Fumagalli, F da Silva Emery
Tetrahedron letters 56 (18), 2307-2310, 2015
142015
Structure-activity relationships and mechanism of action of tetragomycin derivatives as inhibitors of Staphylococcus aureus staphyloxanthin biosynthesis
L Ribeiro, F Fumagalli, RB Mello, TQ Froes, MVS da Silva, SMV Gómez, ...
Microbial pathogenesis 144, 104127, 2020
132020
Arginine-conjugated chitosan nanoparticles for topical arginine release in wounds
DNR Shikida, LF Dalmolin, F Fumagalli, F da Silva Emery, RFV Lopez
Journal of Drug Delivery Science and Technology 61, 102115, 2021
102021
Lapachol biotransformation by filamentous fungi yields bioactive quinone derivatives and lapachol-stimulated secondary metabolites
L Barbosa Coitinho, F Fumagalli, NG da Rosa-Garzon, F da Silva Emery, ...
Preparative Biochemistry & Biotechnology 49 (5), 459-463, 2019
42019
Fármacos Anticorpos Monoclonais para o Tratamento do Câncer: uma Perspectiva Brasileira
JT de Menezes, MC Theisen, V da Costa Flores, F Fumagalli
Revista Brasileira de Cancerologia 70 (1), 2024
2024
Poly-ε-caprolactone based nanoparticles for delivery of genistein in melanoma treatment
JP Abriata, MT Luiz, JSR Viegas, F Fumagalli, SMG Melo, FS Emery, ...
Brazilian Journal of Pharmaceutical Sciences 60, e22542, 2024
2024
Learning from the In vitro Biological Activity Data of Current Antiviral Medicines for the Successful Development of New Antiviral Drug Candidates
MB Fontoura, F Fumagalli
Letters in Drug Design & Discovery 21 (2), 203-208, 2024
2024
Front Cover: Synthesis and Structure− Activity Relationships of Imidazopyridine/Pyrimidine‐and Furopyridine‐Based Anti‐infective Agents against Trypanosomiases (6/2021)
D G. Silva, A Junker, S MG de Melo, F Fumagalli, J Robert Gillespie, ...
ChemMedChem 16 (6), 898-898, 2021
2021
Síntese, funcionalização e prospecção biológica de fragmentos heterocíclicos baseados em núcleos heteroaromáticos subexplorados
F Fumagalli
Universidade de São Paulo, 2019
2019
Enzymatic activity evaluation of novel adenosine derivatives as Abl kinase inhibitors
F Fumagalli, F da Silva Emery, H de Paula, PAB Morais
Galoá, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20